Values First Advisors, Inc. Collegium Pharmaceutical, Inc Transaction History

Values First Advisors, Inc.

  • $165 Million
  • Q2 2024

A detailed history of Values First Advisors, Inc. transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Values First Advisors, Inc. holds 16,993 shares of COLL stock, worth $674,622. This represents 0.33% of its overall portfolio holdings.

Number of Shares
16,993
Previous 15,936 6.63%
Holding current value
$674,622
Previous $618,000 11.49%
% of portfolio
0.33%
Previous 0.36%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 19, 2024
BUY
$31.36 - $39.99 $33,147 - $42,269
1,057 Added 6.63%
16,993 $547,000
Q1 2024

Apr 23, 2024
SELL
$31.23 - $40.91 $559,922 - $733,475
-17,929 Reduced 52.94%
15,936 $618,000
Q4 2023

Jan 18, 2024
SELL
$21.16 - $30.8 $204,024 - $296,973
-9,642 Reduced 22.16%
33,865 $1.04 Million
Q3 2023

Nov 08, 2023
BUY
$21.23 - $24.28 $139,205 - $159,203
6,557 Added 17.75%
43,507 $972,000
Q2 2023

Aug 02, 2023
BUY
$21.06 - $24.0 $154,264 - $175,800
7,325 Added 24.73%
36,950 $794,000
Q1 2023

May 15, 2023
SELL
$23.0 - $29.88 $414,069 - $537,929
-18,003 Reduced 37.8%
29,625 $710,000
Q4 2022

Jan 20, 2023
BUY
$16.14 - $23.55 $35,395 - $51,645
2,193 Added 4.83%
47,628 $0
Q3 2022

Dec 02, 2022
SELL
$15.46 - $20.1 $40,999 - $53,305
-2,652 Reduced 5.52%
45,435 $728,000
Q2 2022

Jul 20, 2022
BUY
$14.22 - $20.88 $35,180 - $51,657
2,474 Added 5.42%
48,087 $852,000
Q1 2022

May 03, 2022
BUY
$17.2 - $22.5 $56,777 - $74,272
3,301 Added 7.8%
45,613 $929,000
Q4 2021

Mar 10, 2022
BUY
$17.5 - $21.35 $740,460 - $903,361
42,312 New
42,312 $790,000
Q3 2021

Nov 15, 2022
SELL
$17.75 - $25.39 $112,073 - $160,312
-6,314 Reduced 13.13%
41,773 $825,000
Q2 2021

Nov 15, 2022
BUY
$21.74 - $25.28 $94,025 - $109,336
4,325 Added 13.15%
37,222 $880,000
Q1 2021

Nov 15, 2022
SELL
$19.25 - $26.1 $292,407 - $396,459
-15,190 Reduced 31.59%
32,897 $780,000
Q4 2020

Nov 15, 2022
BUY
$17.83 - $22.29 $139,038 - $173,817
7,798 Added 24.96%
39,039 $782,000
Q3 2020

Nov 15, 2022
BUY
$15.78 - $20.82 $109,386 - $144,324
6,932 Added 28.52%
31,241 $650,000
Q2 2020

Nov 15, 2022
SELL
$15.49 - $23.51 $236,842 - $359,467
-15,290 Reduced 38.61%
24,309 $425,000
Q1 2020

Jan 09, 2023
SELL
$13.89 - $25.45 $292,940 - $536,740
-21,090 Reduced 46.42%
24,345 $398 Million
Q4 2019

Nov 15, 2022
SELL
$10.7 - $22.24 $90,821 - $188,773
-8,488 Reduced 17.65%
39,599 $815,000

Others Institutions Holding COLL

# of Institutions
236
Shares Held
39.4M
Call Options Held
84.2K
Put Options Held
18.6K
View Full List

About COLLEGIUM PHARMACEUTICAL, INC

COLL Quotes by TradingView
  • Ticker COLL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 34,126,200
  • Market Cap $1.35B
  • Description
  • Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...
More about COLL
Track This Portfolio

Track Values First Advisors, Inc. Portfolio

Follow Values First Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Values First Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Values First Advisors, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email